Cholecystokinin

"Cholecystokinin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.

Descriptor ID	D002766
MeSH Number(s)	D06.472.317.152 D12.644.120
Concept/Terms	Cholecystokinin Cholecystokinin Uropancreozymin Pancreozymin CCK-33 CCK-33 Cholecystokinin 33

Below are MeSH descriptors whose meaning is more general than "Cholecystokinin".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gastrointestinal Hormones [D06.472.317]
Cholecystokinin [D06.472.317.152]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Cholecystokinin [D12.644.120]

Below are MeSH descriptors whose meaning is related to "Cholecystokinin".

Below are MeSH descriptors whose meaning is more specific than "Cholecystokinin".

Cholecystokinin
Sincalide

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cholecystokinin" by people in this website by year, and whether "Cholecystokinin" was a major or minor topic of these publications.

Bar chart showing 7 publications over 6 distinct years, with a maximum of 2 publications in 1997

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1997	0	2	2
2001	1	0	1
2006	1	0	1
2014	0	1	1
2019	0	1	1

Below are the most recent publications written about "Cholecystokinin" by people in Profiles.

Mottalib A, Abrahamson MJ, Pober DM, Polak R, Eldib AH, Tomah S, Ashrafzadeh S, Hamdy O. Effect of diabetes-specific nutrition formulas on satiety and hunger hormones in patients with type 2 diabetes. Nutr Diabetes. 2019 09 24; 9(1):26.

View in: PubMed
Tatard-Leitman VM, Jutzeler CR, Suh J, Saunders JA, Billingslea EN, Morita S, White R, Featherstone RE, Ray R, Ortinski PI, Banerjee A, Gandal MJ, Lin R, Alexandrescu A, Liang Y, Gur RE, Borgmann-Winter KE, Carlson GC, Hahn CG, Siegel SJ. Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biol Psychiatry. 2015 Mar 15; 77(6):556-68.

View in: PubMed
Kierson JA, Dimatteo DM, Locke RG, Mackley AB, Spear ML. Ghrelin and cholecystokinin in term and preterm human breast milk. Acta Paediatr. 2006 Aug; 95(8):991-5.

View in: PubMed
Weinberg DS, Heyt GJ, Cavanagh M, Pitchon D, McGlynn KA, London WT. Cholecystokinin and gastrin levels are not elevated in human pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2001 Jun; 10(6):721-2.

View in: PubMed
Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest. 1997 Aug 01; 100(3):597-603.

View in: PubMed
Obourn JD, Frame SR, Bell RH, Longnecker DS, Elliott GS, Cook JC. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643. Toxicol Appl Pharmacol. 1997 Aug; 145(2):425-36.

View in: PubMed
Lu LJ, Anderson KE, Gomez G, Nealon WH. Decreased plasma levels of cholecystokinin in healthy males after chronic ingestion of a heat-treated soya product. Cancer Lett. 1995 Apr 14; 90(2):149-55.

View in: PubMed
Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology. 1994 Oct; 107(4):1135-46.

View in: PubMed
Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Ann N Y Acad Sci. 1994 Mar 23; 713:439-41.

View in: PubMed
Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 1993 Sep 01; 53(17):3925-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement